Company: MIRA
Filing Date: 2025-06-17
Form Type: PREM14A
Source: 0001641172-25-015340
Chunk: 23

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-06-17
Form: PREM14A
Chunk 23
---
19, 2026, as reported on The Nasdaq Global Market, was $1.20 per share. As of , 2025, the record date for the MIRA virtual special meeting, there were holders of record of the MIRA Common Stock.

Dividends

MIRA has never declared or paid any cash dividends on the MIRA Common Stock and does not anticipate paying cash dividends on the MIRA Common Stock for the foreseeable future. Notwithstanding the foregoing, any determination to pay cash dividends subsequent to the Merger will be at the discretion of MIRA’s then-current board of directors and will depend upon a number of factors, including MIRA’s results of operations, financial condition, future prospects, contractual restrictions, restrictions imposed by applicable law and other factors the then-current board of directors deems relevant.

SKNY has never declared or paid any cash dividends on shares of SKNY Capital Stock, and SKNY and does not anticipate paying any cash dividends on shares of its common stock in the foreseeable future.

| 11 |

<div align='center'>RISK FACTORS</div>

Following the Merger, MIRA will be faced with a market environment that cannot be predicted and that involves significant risks, many of which will be beyond its control. In addition to the other information contained in this proxy statement, you should carefully consider the material risks described below before deciding how to vote your shares of MIRA Common Stock. You should also read and consider the other information in this proxy statement. Please see the section titled “Where You Can Find More Information.”

If any of the following risks and uncertainties develop into actual events, these events could have a material adverse effect on the business, financial condition and results of operations of MIRA. In addition, past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods.

Risks Related to SKNY

Because SKNY has a limited operating history, you may not be able to accurately evaluate SKNY’s operations.

SKNY has had no operations to date, and therefore, SKNY has a limited operating history upon which to evaluate the merits of investing in SKNY. Potential investors should be aware of the difficulties normally encountered by new companies and the high rate of failure of such enterprises. The likelihood of success must be considered in light of the problems, expenses, difficulties, complications, and delays encountered in connection with the operations that SKNY plans to undertake. These potential problems include, but are not limited to, unanticipated